FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4283022376> ?p ?o ?g. }

• W4283022376 abstract "Cystinosis is a rare autosomal recessive lysosomal storage disease, associated with high morbidity and mortality. Mutations in the CTNS gene disable a membrane protein responsible for the transport of cystine out of the lysosome. Loss of transporter function leads to intralysosomal cystine accumulation and long-term damage to various tissues and organs, including the kidneys, eyes, liver, muscles, pancreas, and brain. The only cystine-depletion therapy for treatment of cystinosis is cysteamine which requires frequent administration of high doses and often causes gastrointestinal pain as well as pungent sulfurous odor in patients. The current in vitro study evaluated antioxidants, N-acetylcysteine amide (NACA; NPI-001) and (2R,2R')-3,3'-disulfanediyl bis(2-acetamidopropanamide) (diNACA; NPI-002), as potential treatments for cystinosis.Cytotoxicity of cysteamine, NACA and diNACA was evaluated in cultured human cystinotic fibroblasts (HCFs). HCFs were cultured in 96 well plates incubated for 0-72 h in the presence of 25, 50 or 75 μM each of either cysteamine, NACA or diNACA along with an untreated control. Media was removed and cell viability assessed. Next, cystine-depleting activities of cysteamine, NACA and diNACA were screened in HCFs cell culture utilizing an inexpensive, proven colorimetric assay. HCFs were seeded and allowed to reach approximately 80% confluence before the addition of the test articles: 50 μM of either cysteamine, NACA or diNACA in media along with an untreated control. HCFs were incubated, harvested, and cystine was reduced to cysteine, the concentration of which was then determined per quantity of protein compared to a cysteine standard. Statistically significant cystine depletion was determined by paired t-test versus untreated control (p < 0.05).Neither cysteamine, NACA nor diNACA at 25, 50 or 75 μM caused cytotoxicity in HCFs. Treatment with all tested concentrations (25, 50 or 75 µM) of either NACA or diNACA at 48 or 72 h resulted in statistically significant increases in cell viability, relative to untreated control, whereas the higher concentrations (50 or 75 µM) of cysteamine achieved statistical significance at both timepoints but not the lowest concentration (25 µM). All test articles depleted cystine from HCFs compared to control. NACA depletion of cystine was statistically superior to cysteamine at 6, 24 and 48 h and numerically greater at 72 h. DiNACA depletion of cystine was statistically superior to cysteamine at 6 and 48 h, slightly numerically greater at 24 h and slightly less at 72 h.NACA and diNACA were non cytotoxic to HCFs and significantly increased cell viability. Cystine reduction was determined as percent of control after incubation with 50 µM of NACA, diNACA or cysteamine in HCFs cell culture for 6, 24, 48 and 72 h. Of the three test articles, NACA exhibited most rapid and greatest potency in cystine reduction. Rank order potency for cystine reduction over time was observed, NACA > diNACA ≥ cysteamine. Therefore, further study of NACA and diNACA as potential treatments for cystinosis is warranted." @default.
• W4283022376 created "2022-06-18" @default.
• W4283022376 creator A5016661308 @default.
• W4283022376 creator A5036740420 @default.
• W4283022376 creator A5083158252 @default.
• W4283022376 date "2022-06-16" @default.
• W4283022376 modified "2023-09-25" @default.
• W4283022376 title "Evaluation of NACA and diNACA in human cystinosis fibroblast cell cultures as potential treatments for cystinosis" @default.
• W4283022376 cites W1598843348 @default.
• W4283022376 cites W1819048918 @default.
• W4283022376 cites W1975479135 @default.
• W4283022376 cites W1984525809 @default.
• W4283022376 cites W1988743548 @default.
• W4283022376 cites W1993691372 @default.
• W4283022376 cites W1994925510 @default.
• W4283022376 cites W1996130473 @default.
• W4283022376 cites W2011597935 @default.
• W4283022376 cites W2029870086 @default.
• W4283022376 cites W2050022593 @default.
• W4283022376 cites W2054523613 @default.
• W4283022376 cites W2057191559 @default.
• W4283022376 cites W2092547860 @default.
• W4283022376 cites W2098903502 @default.
• W4283022376 cites W2104934361 @default.
• W4283022376 cites W2109044503 @default.
• W4283022376 cites W2111278403 @default.
• W4283022376 cites W2149297173 @default.
• W4283022376 cites W2149736600 @default.
• W4283022376 cites W2163080522 @default.
• W4283022376 cites W2168938422 @default.
• W4283022376 cites W2206857117 @default.
• W4283022376 cites W2474023059 @default.
• W4283022376 cites W2781352277 @default.
• W4283022376 cites W2913501911 @default.
• W4283022376 cites W2987854688 @default.
• W4283022376 cites W3036730707 @default.
• W4283022376 cites W3217028541 @default.
• W4283022376 cites W2092085949 @default.
• W4283022376 doi "https://doi.org/10.1186/s13023-022-02367-w" @default.
• W4283022376 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35710564" @default.
• W4283022376 hasPublicationYear "2022" @default.
• W4283022376 type Work @default.
• W4283022376 citedByCount "0" @default.
• W4283022376 crossrefType "journal-article" @default.
• W4283022376 hasAuthorship W4283022376A5016661308 @default.
• W4283022376 hasAuthorship W4283022376A5036740420 @default.
• W4283022376 hasAuthorship W4283022376A5083158252 @default.
• W4283022376 hasBestOaLocation W42830223761 @default.
• W4283022376 hasConcept C126322002 @default.
• W4283022376 hasConcept C134018914 @default.
• W4283022376 hasConcept C153911025 @default.
• W4283022376 hasConcept C181199279 @default.
• W4283022376 hasConcept C185592680 @default.
• W4283022376 hasConcept C2776609658 @default.
• W4283022376 hasConcept C2777608289 @default.
• W4283022376 hasConcept C2778518273 @default.
• W4283022376 hasConcept C2779201268 @default.
• W4283022376 hasConcept C55493867 @default.
• W4283022376 hasConcept C71924100 @default.
• W4283022376 hasConcept C86803240 @default.
• W4283022376 hasConceptScore W4283022376C126322002 @default.
• W4283022376 hasConceptScore W4283022376C134018914 @default.
• W4283022376 hasConceptScore W4283022376C153911025 @default.
• W4283022376 hasConceptScore W4283022376C181199279 @default.
• W4283022376 hasConceptScore W4283022376C185592680 @default.
• W4283022376 hasConceptScore W4283022376C2776609658 @default.
• W4283022376 hasConceptScore W4283022376C2777608289 @default.
• W4283022376 hasConceptScore W4283022376C2778518273 @default.
• W4283022376 hasConceptScore W4283022376C2779201268 @default.
• W4283022376 hasConceptScore W4283022376C55493867 @default.
• W4283022376 hasConceptScore W4283022376C71924100 @default.
• W4283022376 hasConceptScore W4283022376C86803240 @default.
• W4283022376 hasIssue "1" @default.
• W4283022376 hasLocation W42830223761 @default.
• W4283022376 hasLocation W42830223762 @default.
• W4283022376 hasLocation W42830223763 @default.
• W4283022376 hasLocation W42830223764 @default.
• W4283022376 hasOpenAccess W4283022376 @default.
• W4283022376 hasPrimaryLocation W42830223761 @default.
• W4283022376 hasRelatedWork W1538098731 @default.
• W4283022376 hasRelatedWork W1603697547 @default.
• W4283022376 hasRelatedWork W161657894 @default.
• W4283022376 hasRelatedWork W1966482644 @default.
• W4283022376 hasRelatedWork W2014202419 @default.
• W4283022376 hasRelatedWork W2126648805 @default.
• W4283022376 hasRelatedWork W2149297173 @default.
• W4283022376 hasRelatedWork W2420388034 @default.
• W4283022376 hasRelatedWork W4220770963 @default.
• W4283022376 hasRelatedWork W4234004356 @default.
• W4283022376 hasVolume "17" @default.
• W4283022376 isParatext "false" @default.
• W4283022376 isRetracted "false" @default.
• W4283022376 workType "article" @default.